3 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Systemic corticosteroids: new trials by email Literature Review of Systemic corticosteroids trials Research Report on Systemic corticosteroids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| How Long Should we Give Steroids for Patients With Severe PCP Systemic corticosteroids - Pneumocystis Pneumonia, Pneumocystis | Phase 4 | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 416 | 2026-01-30 | 2026-01-09 |
| Steroid Use in Treatment of Allergic Reactions to Food Antihistamines, Systemic corticosteroids, Adrenaline (rescue medication) - Anaphylactic Reaction, Anaphylaxis | Phase 4 | Recruiting | Johannes Trueck | 160 | 2026-01-26 | 2026-01-27 |
| Characteristics of Ankylosing Spondylitis Associated Uveitis Adalimumab, Systemic corticosteroids - Uveitis | Completed | Benha University | 22 | 2023-09-01 | 2025-08-11 | |
| Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD Recombinant Human Interleukin-22 IgG2-Fc (F-652), Systemic Corticosteroids - Acute Graft vs Host Disease | Phase 1 / Phase 2 | Completed | EVIVE Biotechnology | 30 | 2016-05-12 | 2021-07-22 |
| Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence Cyclosporins, Retinoids, Systemic corticosteroids - Psoriasis | Phase 4 | Completed | Merck KGaA, Darmstadt, Germany | 41 | 2004-02-01 | 2014-02-27 |
Anaphylaxis (1) · Food Hypersensitivity (1) · Infections (1) · Pneumocystis Infections (1) · Pneumonia (1) · Pneumonia, Pneumocystis (1) · Psoriasis (1) · Spondylitis, Ankylosing (1) · Uveitis (1)
Benha University (1) · EVIVE Biotechnology (1) · Johannes Trueck (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Merck KGaA, Darmstadt, Germany (1)
Canada (1) · Egypt (1) · Switzerland (1) · United States (1)
Doris Ponce, M.D. (1) · Patrick Natta, MD (1)